Nuvaring and Visual field defect - a phase IV clinical study of FDA data

Summary:

Visual field defect is reported as a side effect among people who take Nuvaring (ethinyl estradiol; etonogestrel), especially for people who are female, 20-29 old, have been taking the drug for 6 - 12 months also take Ibuprofen, and have Migraine.

The phase IV clinical study analyzes which people have Visual field defect when taking Nuvaring. It is created by eHealthMe based on reports of 27,664 people who have side effects when taking Nuvaring from the FDA, and is updated regularly.

What is Nuvaring?

Nuvaring has active ingredients of ethinyl estradiol; etonogestrel. It is often used in birth control. eHealthMe is studying from 28,730 Nuvaring users. Check the latest studies of Nuvaring.

What is Visual field defect?

Visual field defect is found to be associated with 769 drugs and 1,036 conditions by eHealthMe. Check the latest studies of Visual field defect.

On Jul, 04, 2026

27,664 people reported to have side effects when taking Nuvaring.
Among them, 36 people (0.13%) have Visual field defect.

Could Nuvaring cause Visual field defect?

Among these 36 people:

How long have people been on Nuvaring when they have Visual field defect? *

What is the gender of people who have Visual field defect when taking Nuvaring? *

female: 100 %
male: 0.0 %

What is the age of people who have Visual field defect when taking Nuvaring? *

What are other drugs people take besides Nuvaring? *

What are other side effects people have besides Visual field defect? *

Headache (pain in head): 14 people, 38.89%
Migraine (headache): 14 people, 38.89%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 13 people, 36.11%
Depression: 13 people, 36.11%
Stress And Anxiety: 10 people, 27.78%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 9 people, 25.00%
Protein S Deficiency: 9 people, 25.00%
Loss Of Consciousness: 9 people, 25.00%
Intracranial Venous Sinus Thrombosis (presence of thrombosis (a blood clot) in the dural venous sinuses, which drain blood from the brain): 9 people, 25.00%
Hypercoagulation (increased tendency for clotting of the blood): 9 people, 25.00%

What are the existing conditions these people have? *

Migraine (headache): 6 people, 16.67%
Headache (pain in head): 3 people, 8.33%
Stress And Anxiety: 2 people, 5.56%
Ovarian Cysts (fluid filled sacs of the ovary): 2 people, 5.56%
Menstruation Irregular: 2 people, 5.56%
Heavy Or Prolong Menstrual Bleeding: 2 people, 5.56%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 5.56%
Neck Pain: 1 person, 2.78%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 2.78%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Nuvaring and have Visual field defect?

- Check whether Visual field defect is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nuvaring:

Nuvaring (28,730 reports)

Visual field defect treatments and more:

Visual field defect (8,900 reports)

How severe was Visual field defect and when was it recovered:

Visual field defect in Nuvaring

Expand to all the drugs that have ingredients of ethinyl estradiol; etonogestrel:

Visual field defect and drugs with ingredients of ethinyl estradiol; etonogestrel (36 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nuvaring:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual field defect:

Visual field defect (769 drugs)

Browse all the conditions that are associated with Visual field defect:

Visual field defect (1,036 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; etonogestrel (the active ingredients of Nuvaring) and Nuvaring (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.